financetom
Business
financetom
/
Business
/
L3Harris Gets $587 Million US Navy Contract to Provide Jamming Pods
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
L3Harris Gets $587 Million US Navy Contract to Provide Jamming Pods
Sep 13, 2024 1:35 PM

04:39 PM EDT, 09/12/2024 (MT Newswires) -- L3Harris Technologies ( LHX ) said Thursday it has been awarded a five-year contract worth up to $587.4 million to provide tactical jamming pods for the US Navy.

The company said it will deliver eight operational prototype pods to the US Naval Air Systems Command for fleet evaluation and and additional test assets over the next five years.

Price: 228.21, Change: +0.04, Percent Change: +0.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Medical device maker Biofrontera Q3 revenue falls more than expected on advanced purchases in 2024
Medical device maker Biofrontera Q3 revenue falls more than expected on advanced purchases in 2024
Nov 13, 2025
Overview * Biofrontera Q3 revenue of $7 mln missed analyst expectations due to advanced purchases in 2024 * Adjusted EBITDA for Q3 was negative $6 mln, missing analyst estimates * Company completed purchase of US Ameluz and RhodoLED assets, reducing royalty payments Outlook * Company anticipates substantial 4Q25 and annual revenue growth due to price normalization * Biofrontera expects enhanced...
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved